Morgan Stanley analyst Ronald Kamdem lowered the firm’s price target on Lineage (LINE) to $95 from $100 and keeps an Overweight rating on the shares after updating the firm’s FY24, FY25 and FY26 AFFO estimates.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LINE: